COVID-19 cases among college students are inevitable. If you’re a college student – or the parent of one – you need to know who’s going to foot the bill if they get sick.
Articles on Health insurance
Displaying 61 - 80 of 149 articles
Studies repeatedly have shown that health care in general and the high cost of drugs in particular are among the top concerns of US voters. But with coronavirus, the issue may fade from prominence.
Help is out there for those many who have lost health insurance because of the pandemic. You can thank Obamacare.
COVID19 threatens to reverse years of Indonesia’s positive trends in poverty alleviation. We highlight lessons from past policies to prevent another poverty hike during the pandemic.
The pandemic magnifies existing imbalances in wealth, access to health care and workplace rights.
In the UK, nobody collects patients’ insurance information or credit card details. There’s simply no charge for services, including doctor visits, ambulances and hospitalizations.
Ghana’s lack of a palliative care policy is posing a significant challenge to effective healthcare for cancer patients.
It’s not the price of health care that should concern us. It’s the cost. There’s a distinction, and it matters. Here’s why.
High prescription drug costs are a widespread concern for consumers and policymakers. For patients who need specialty drugs, though, the problem is even worse, with no relief in sight.
In the wake of the New Deal, the business community realized that appealing to widely shared American values could get the public to oppose measures that curbed corporate power.
Young people don’t see the value in private health insurance and are dropping their cover in droves. Allowing under 55s to pay lower premiums, based on their lower risk, could keep them in the system.
Just how big a problem are medical bankruptcies? For someone going through one, it’s devastating. And it happens far more often than you might think.
Patients often want the option to be treated at home rather than being admitted to hospital. But it’s much less likely to happen if you’re a private patient.
Nearly 160 million Americans get insurance through employers, but that does not mean it’s good social policy. An economist explains some aspects of employer-sponsored insurance that don’t work well.
Are more technologically advanced prosthetics and orthotics actually better for improving health? Or do we just think they are better? And most importantly, how do we figure it out?
People are more willing to participate in fitness tracker-based insurance policies when they are in control of their participation.
In just five years, the number of mobile-money accounts in Ghana have jumped six-fold, providing fresh perspective on the country’s digital transformation.
In the US, poverty is measured by income level. But that measure misses many other aspects of poverty – like unemployment, poor health and a lack of health insurance.
A trip to the emergency room can turn expensive fast if the providers are not in your network. That is happening more often, as some doctors choose to opt out of insurance plans. Here’s why.
The over-medicalization of back pain is a global concern. New research in Canada shows that people with lower income as well as rural and remote dwellers are less likely to access physiotherapy care.
Top contributors
-
Associate Professor of Public Health, Texas A&M University
-
Associate Professor of Health Law, Policy and Management, Boston University
-
Professor of Health Finance, Weatherhead School of Management & School of Medicine, Case Western Reserve University
-
Assistant Professor of Social, Behavioral and Population Sciences, Tulane University
-
Professor of Health Law and Bioethics, Case Western Reserve University
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Research scientist of Health Policy and Economics, University of Southern California
-
Research Scientist and Director of Research Training in Health Policy and Economics, University of Southern California
-
Professor of Health Economics, The University of Melbourne
-
Assistant professor of Health Policy & Administration, University of Illinois Chicago
-
Senior Research Fellow and Lecturer of Gerontology, UMass Boston
-
Quintiles Professor of Pharmaceutical Development and Regulatory Innovation, Schaeffer Center for Health Policy and Economics, University of Southern California
-
Professor, Department of Health Policy, London School of Economics and Political Science
-
Associate Professor of Health Policy, Management and Behavior, University at Albany, State University of New York
-
Assistant Professor of Health Policy and Managment, School of Public Health, Texas A&M University
